Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN2A | Q99250 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.52 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.49 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29395615 | 1.00 | SCN2A (0.57) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL18470136 | 0.88 | KMT2A (0.47) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL4649466 | 0.84 | POLB (0.65) | POLBCYP3A4NFKB1PMP22GAA | |
| SCHEMBL9324781 | 0.81 | KMT2A (0.46) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL18917454 | 0.80 | CYP3A4 (0.65) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL11860388 | 0.80 | ADORA2A (0.62) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL3382926 | 0.79 | KMT2A (0.56) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL3381865 | 0.79 | KMT2A (0.56) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL3380658 | 0.79 | KMT2A (0.56) | SCN2APOLBCYP3A4NFKB1PMP22 | |
| SCHEMBL18470140 | 0.79 | KMT2A (0.46) | SCN2APOLBCYP3A4NFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148043-B2 | Silsesquioxane resin systems with base additives bearing electron-attracting functionalities | DOW CORNING CORPORATION (US) | 2012-04-03 | — | — | US | claimed |
| JP-2009543135-A | — | — | 2009-12-03 | — | — | JP | claimed |
| US-20090202941-A1 | SILSESQUIOXANE RESIN SYSTEMS WITH BASE ADDITIVES BEARING ELECTRON-ATTRACTING FUNCTIONALITIES | DOW CORNING CORPORATION (US) | 2009-08-13 | — | — | US | claimed |
| WO-2008002975-A2 | SILSESQUIOXANE RESIN SYSTEMS WITH BASE ADDITIVES BEARING ELECTRON- ATTRACTING FUNCTIONALITIES | DOW CORNING CORPORATION (US) | 2008-01-03 | — | — | WO | claimed |
| US-20240337943-A1 | HIGH REFRACTIVE INDEX PHOTORESIST COMPOSITION | DOW SILICONES CORP (US) | 2024-10-10 | — | — | US | disclosed |
| CN-118103773-A | High refractive index photoresist composition | 美国陶氏有机硅公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20230321043-A1 | COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES | UNIV COPENHAGEN (DK) | 2023-10-12 | — | — | US | disclosed |
| US-20230321043-A1 | COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES | UNIV COPENHAGEN (DK) | 2023-10-12 | — | — | US | disclosed |
| WO-2023064023-A1 | HIGH REFRACTIVE INDEX PHOTORESIST COMPOSITION | DOW SILICONES CORPORATION (US) | 2023-04-20 | — | — | WO | disclosed |
| US-11370888-B2 | Silicon-rich silsesquioxane resins | DOW SILICONES CORPORATION (US) | 2022-06-28 | — | — | US | disclosed |
| CN-109415513-B | Silicon-rich silsesquioxane resins | 美国陶氏有机硅公司 | 2022-02-25 | — | — | CN | disclosed |
| US-20190211155-A1 | SILICON-RICH SILSESQUIOXANE RESINS | DOW SILICONES CORPORATION | 2019-07-11 | — | — | US | disclosed |
| US-20010006767-A1 | Developing solution and method of forming polyimide pattern by using the developing solution | YOSHIAKI KAWAMONZEN | 2001-07-05 | — | — | US | disclosed |
| US-6183934-B1 | FOE USE IN FORMATION OF PATTERN OF INSULATION FILM, PASSIVATION FILM, .ALPHA.-RAY SHIELDING FILM, OPTICAL WAVEGUIDE | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-02-06 | — | — | US | disclosed |
| US-6159654-A | Negative photosensitive polymer composition of a thermosetting polymer precursor curable by cyclodehydration upon heating | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-12-12 | — | — | US | disclosed |
| US-6001517-A | A THERMOSETTING POLYMER WHICH CAN BE CURED THROUGH CYCLODEHYDRATION UPON HEATING AND A CURE ACCELERATOR WHICH CAN BE DEACTIVATED OF ITS CURE ACCELERATION PROPERTY BY IRRIDIATION OF LIGHT | KABUSHIKI KAISHA TOSHIBA (JP) | 1999-12-14 | — | — | US | disclosed |
| US-5578697-A | DIELECTRIC POLYMERS FOR ELECTRONICS | KABUSHIKI KAISHA TOSHIBA (JP) | 1996-11-26 | — | — | US | disclosed |
| EP-0416749-B1 | Substituted 4-aminoquinolines | SMITHKLINE BEECHAM INTERCREDIT (NL) | 1994-08-17 | — | — | EP | disclosed |
| US-5082841-A | Enzyme inhibitor | SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) | 1992-01-21 | — | — | US | disclosed |
| EP-0416749-A2 | Substituted 4-aminoquinolines | SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) | 1991-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321043-A1 | COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES | GMPS, PDE11A, CGAS | SCN2A 3326/4885POLB 320/4885CYP3A4 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.